Close Menu

NEW YORK (GenomeWeb) – Premas Life Sciences announced today that it has signed an agreement to acquire the exclusive distribution rights in India to IncellDx's portfolio of immune-oncology and oncology diagnostic products.

Included in the deal are IncellDx's OncoTect single-cell assay for quantifying PD-L1 on tumor cells and immune cell subtypes; its single-cell assay for HPV E6/E7 mRNA detection in cervical samples; and its IncellPrep single-cell preparation kit for solid tissues including tumors.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Mar
21
Sponsored by
Loop Genomics

This webinar provides a comparison of next-generation sequencing (NGS) approaches for human transcriptome sequencing, including short-read Illumina sequencing and synthetic long-read sequencing technology.

Mar
26
Sponsored by
PerkinElmer

This webinar will address the current status and future directions for massively high-throughput genomics for plant and animal breeding and research.

Mar
27
Sponsored by
Swift Biosciences

Sequencing workflows require library quantification and normalization to ensure data quality and reduce cost. 

Mar
28
Sponsored by
Qiagen

The Human Gene Mutation Database (HGMD) is a manually curated, comprehensive collection of disease-causing, germline mutations. Since 1996, a team of experts has manually catalogued over a quarter of a million mutations for the database.